Imaging by 4 DFlow in Patients With Tetralogy of Fallot
NCT ID: NCT03542968
Last Updated: 2020-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2017-10-12
2020-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
4D Flow CMR Imaging is a new imaging modality able to assess all of these parameters faster (8 min vs 30 min) and more comfortably.
The aim of this study is to compare conventionnal CMR and 4D Flow CMR for the assessment of these parameters (ventricular volume, ventricular systolic function, and regurgitation of the pulmonary pathway).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
4D Velocity Mapping of the Heart in rTOF Patients
NCT02980614
4DFlow Magnetic Resonance Imaging in Patients With Pulmonary Hypertension Associated With Congenital Heart Disease
NCT03928002
Effect of Contouring Techniques on CMR Assessment of the Right Ventricle in Repaired Tetraology of Fallot
NCT04359940
4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy
NCT04439942
Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.
NCT02467062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Among these pathologies, the tetralogy of Fallot is indicative of the increasing importance of cardiac MRI. In this disease, strong parameters has been identifies for the follow to prevent right ventricle dysfunction and ventricular arrhythmias. They rely on right ventricle volumes and on the pulmonary artery regurgitation, both using cardiac MRI.
However, this imaging modality imposes constraints such as a long acquisition times (30 to 40 min) or the need to hold apneas, which may render the procedure uncomfortable, even more in the case of very young patients.
The idea of exploring a new imaging modality is therefore based on the willingness to offer a faster and more comfortable examination. 4D Flow MRI could enable conventionnal parameters, detection of both normal and abnormal right heart flow patterns, and may allow comprehensive analysis of post-surgically altered geometries and hemodynamics.
4D Flow MRI cardiac imaging is :
* A single and faster acquisition (8 to 15 minutes) that cardiac MRI.
* A free breathing acquisition Imaging modality.
* A quite-isotropic assessment.
* A technically simple exam (a single sequence requiring low competence).
* And offers unlimited post processing.
The investigators hypothesize that 4D MRI is non-inferior to 2D MRI in patients with corrected tetralogy of Fallot, for the evaluation of conventional cardiac evaluation parameters: ventricular volume, ventricular systolic function, and regurgitation of the pulmonary pathway.
The investigators hypothesize that 4D MRI is superior to 2D MRI in patients with corrected tetralogy of Fallot, as ti allows to identifying new predictors of ventricular dysfunction such as intravenous extracardiac turbulent / laminar flow character, preferential orientation, flow distribution and trans-tricuspid diastolic flow.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4D magnetic resonance imaging
MRI, 4D imaging, acquisition and analysis of 4D cardiac MRI images-A single, faster acquisition (8 to 15 minutes).
magnetic resonance imaging
Acquisition 4D Flow magnetic resonance Imaging-8 minutes
2D magnetic resonance imaging
MRI, 2D imaging, acquisition and analysis of 2D cardiac MRI
magnetic resonance imaging
Acquisition 4D Flow magnetic resonance Imaging-8 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
magnetic resonance imaging
Acquisition 4D Flow magnetic resonance Imaging-8 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* giving their informed consent for the study;
* with a corrected tetralogy of Fallot;
* sent for a follow-up imaging examination with endomyocardial fibrosis screening;
Exclusion Criteria
* children \<10 years old;
* All contraindications inherent to MRI: (claustrophobia, ferromagnetic intracorporeal foreign bodies)
* Contraindication to contrast media injection (Gadolinium)
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Chirurgical Marie Lannelongue
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Antoine ISORNI, Doctor
Role: PRINCIPAL_INVESTIGATOR
Hôpital Marie Lannelongue
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Marie Lannelongue
Le Plessis-Robinson, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01482-51
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.